Effect of denosumab treatment on bone mineral density and bone turnover markers in osteoporotic patients: real-life experience 2-year follow-up

DİNÇER YAZAN C., BUĞDAYCI O., ILGIN C., YAVUZ D.

ARCHIVES OF OSTEOPOROSIS, cilt.17, sa.1, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1007/s11657-022-01145-2
  • Dergi Adı: ARCHIVES OF OSTEOPOROSIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Anahtar Kelimeler: Denosumab, Bone mineral density, Real-life experience, POSTMENOPAUSAL WOMEN, FRACTURE, THERAPY, RISK, DISCONTINUATION
  • Marmara Üniversitesi Adresli: Evet

Özet

Denosumab leads to improvements in BMD levels and is a well-tolerated agent according to results of randomized controlled studies but results in real-life setting are important to evaluate drug adherence and real-life efficiency. In this study, we present the results of 305 patients that were treated with denosumab in our clinic.